Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Apperley

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2009
Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantationCatherine Cordonnier, Myriam Labopin, Virginie Chesnel, et al.
Haematologica|April 21, 2009
The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinibJamshid Sorouri Khorashad, Simon Wagner, Liat Greener, et al.
British Journal of Haematology|August 1, 2020
A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemiaGraeme Smith, Jane Apperley, Dragana Milojkovic, et al.
Eclinicalmedicine|November 12, 2019
Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute LeukaemiaAlois Gratwohl, Rafael Duarte, John A Snowden, et al.
Blood|February 29, 2012
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantationAristeidis Chaidos, Scott Patterson, Richard Szydlo, et al.
Blood|December 23, 2006
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisisJorge Cortes, Philippe Rousselot, Dong-Wook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2011
EBMT risk score predicts outcome of allogeneic hematopoietic stem cell transplantation in patients who have failed a previous transplantation procedureKatayoun Rezvani, Edward J Kanfer, David Marin, et al.
Vaccine|February 2, 2010
Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trialCatherine Cordonnier, Myriam Labopin, Virginie Chesnel, et al.
Blood|July 2, 2002
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell doseCesare Guglielmi, William Arcese, Francesco Dazzi, et al.
Haematologica|July 6, 2014
Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMTYves Chalandon, Jakob R Passweg, Cesare Guglielmi, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2009
Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantationCatherine Cordonnier, Myriam Labopin, Virginie Chesnel, et al.
Haematologica|April 21, 2009
The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinibJamshid Sorouri Khorashad, Simon Wagner, Liat Greener, et al.
British Journal of Haematology|August 1, 2020
A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemiaGraeme Smith, Jane Apperley, Dragana Milojkovic, et al.
Eclinicalmedicine|November 12, 2019
Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute LeukaemiaAlois Gratwohl, Rafael Duarte, John A Snowden, et al.
Blood|February 29, 2012
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantationAristeidis Chaidos, Scott Patterson, Richard Szydlo, et al.
Blood|December 23, 2006
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisisJorge Cortes, Philippe Rousselot, Dong-Wook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2011
EBMT risk score predicts outcome of allogeneic hematopoietic stem cell transplantation in patients who have failed a previous transplantation procedureKatayoun Rezvani, Edward J Kanfer, David Marin, et al.
Vaccine|February 2, 2010
Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trialCatherine Cordonnier, Myriam Labopin, Virginie Chesnel, et al.
Blood|July 2, 2002
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell doseCesare Guglielmi, William Arcese, Francesco Dazzi, et al.
Haematologica|July 6, 2014
Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMTYves Chalandon, Jakob R Passweg, Cesare Guglielmi, et al.
Pageof 12